CMTP (@CMTP_Baltimore) header
CMTP (@CMTP_Baltimore) profile picture

Center for Medical Technology Policy Home of #GPC (Green Park Collaborative), a multi-stakeholder forum developing #CoreOutcomeSets for clinical trial design.

Baltimore, Maryland
Joined May 2012
Photo by CMTP (@CMTP_Baltimore)Photo by CMTP (@CMTP_Baltimore)Photo by CMTP (@CMTP_Baltimore)Photo by CMTP (@CMTP_Baltimore)Photo by CMTP (@CMTP_Baltimore)Photo by CMTP (@CMTP_Baltimore)Photo by CMTP (@CMTP_Baltimore)Photo by CMTP (@CMTP_Baltimore)Photo by CMTP (@CMTP_Baltimore)Photo by CMTP (@CMTP_Baltimore)
Replying to @CMTP_Baltimore
@CMTP_Baltimore is recruiting men/adolescents age 15+ with moderate/severe haemophilia A or B for study on gene therapy and mental health. Participants will be paid $100 USD or equivalent for a 90-minute online interview. More info: ow.ly/o65v50FNj2a
1
1
August is National Immunization Awareness Month (#NIAM), a time to highlight the importance of vaccination for people of all ages. Spread the word about being #VaccineReady and stay up to date with recommended #vaccinations: fal.cn/3hnQt. #iVax2Protect
It is estimated that 25–30% of people worldwide currently have nonalcoholic fatty liver disease (#NAFLD) & 2–6% have nonalcoholic steatohepatitis (#NASH), the most severe form of NAFLD. Researchers estimate that the prevalence of #NASH could increase by over 50% by 2030. #NASHDay
There are so many things that make the bleeding disorders community unique. That’s why this Bleeding Disorders Awareness Month we are raising awareness from A to Z. #BleedingDisordersAwarenessMonth
3
2
What can Europe do for high quality care in rare diseases? International collaboration crucial, we need to think of costs in a totally new way, member states need to be less concerned about territory-mindedness says @KarinKarlsbro, @AOlauson & T.Andersen @eurordis #RareDiseaseDay
Researchers have developed a faster, less expensive, reliable method for non-invasive prenatal diagnosis of hemophilia A. ow.ly/sqle50yiMEq
If only health economists were in charge... Great piece by @afrakt. tinyurl.com/rh2xtfk #healtheconomics @ashecon #heor @TuftsCEVR
Many factor deficiencies are incredibly rare, the rarest occurring in roughly 1 out of 5 million people. Most have only been discovered in the past 70 years. With your help, researchers can learn more than ever about rare factory deficiencies. ow.ly/fx9I50yagvM
1
3
The term will really only become relevant with Gene Therapy which will be the first irreversible haemophilia therapy. Points to the need for a well informed patient community
A term I heard for the first time at #EAHAD2020 today when referred to #hemophilia is "treatment remorse". This applies to patients who opt for a treatment and then regret their decision. New treatments such as gene therapy can last for years. #haemophilia
6
11
What are we trying to accomplish by Explainable AI? Accuracy, Accountability, Reliability #GartnerDA
3
2
One of the most troubling findings of a recent national survey is how many women with #fibroids wait for years without seeking treatment. It's important to promote more education and awareness around fibroids. https://teapawt.net/t.co/1BrC518eBE #WhyICAREAboutFibroids #WomensHealth
1
1
2
Short-term Quality of Life after Myomectomy for Uterine Fibroids from the Compare-UF Fibroid Registry. ift.tt/34yvXF9
The information gathered in MyBDC can be used by researchers to gain a deeper understanding of how a bleeding disorder impacts an affected individual and family members. ow.ly/pcxc50xMrCC
1
4
7
#60Minutes re-aired its special on a patient being cured of #sicklecell disease through gene therapy. Watch the segment here: sc101.link/60Mins2 And the follow-up segments where they explain the vector used to edit the gene causing sickle cell disease. #sicklecell101
8
1
21
This new paper, joint with @JakubHlavka & @TuftsCEVR's @PaigeLin_HEOR, in @AJMC_Journal, presents 34 outcome-based #qualitymeasures to consider in #oncology payment models. tinyurl.com/wxsmglv @dollendorf @CMTP_Baltimore @SchaefferCenter @RANDCorporation @MWFriedberg
8
1
13
CMTP retweeted
30 million people in Europe live with a #raredisease. #WeWontRest until we make rare diseases even rarer #Care4Rare https://teapawt.net/t.co/dLxjn48Aot
2
38
9
91
Absolutely remarkable to have another targeted agent for #SickleCell approved by #FDA today. Important addition to the toolkit to @ConquerSCD. Potential Game-changers for patients and families – at Chicago, IL
#FDAapproves new drug for the treatment of sickle cell disease in adults and pediatric patients 12 years of age and older: go.usa.gov/xpRB6.
1
17
1
41
How much do you know about uterine fibroids? Increase awareness and get to know these myths. https://teapawt.net/t.co/wzul5ox92f
1
2
5
Had a great time presenting findings from the COMPARE-UF study with colleagues Ebbie Stewart, Sateria Venable, and Evan Myers. (ncbi.nlm.nih.gov/pubmed/3130…). #asrm2019 @UNCOBGYN @FibroidFoun @MayoFibroids @WeCan_WearWhite
1
3
8
Yet ANOTHER publication from our tremendous #MayoClinicFl #CriticalCare team! Well done, guys! @pmorenofranco – at Minnesota, USA
3
2
2
10